Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 803 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 84.37 USD | -2.99% | +2.75% | +12.49% | +115.78% | 11.88 B USD | ||
| 837 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 59.65 USD | -1.16% | +2.95% | +3.90% | +2.23% | 11.53 B USD | ||
| 857 | TECH Bio-Techne Corp - Common Stock | 70.56 USD | -0.07% | -0.24% | +32.04% | +33.36% | 11.05 B USD | ||
| 864 | KRYS Krystal Biotech, Inc. - Common Stock | 365.13 USD | -0.94% | -2.49% | +18.94% | +95.12% | 10.76 B USD | ||
| 872 | ABVX Abivax SA - American Depositary Shares | 137.77 USD | -3.09% | +2.82% | +35.87% | +1637.33% | 10.82 B USD | ||
| 887 | CYTK Cytokinetics, Incorporated - Common Stock | 82.54 USD | -3.53% | -2.70% | +20.32% | +42.07% | 10.27 B USD | ||
| 908 | CORT Corcept Therapeutics Incorporated - Common Stock | 91.49 USD | -2.71% | +0.73% | +23.62% | +24.70% | 9.82 B USD | ||
| 927 | NUVL Nuvalent, Inc. - Class A Common Stock | 123.81 USD | +0.03% | +0.17% | +0.81% | +30.39% | 9.78 B USD | ||
| 928 | KYMR Kymera Therapeutics, Inc. - Common Stock | 118.87 USD | -0.31% | +3.05% | +58.75% | +101.13% | 9.78 B USD | ||
| 944 | HALO Halozyme Therapeutics, Inc. - Common Stock | 79.32 USD | -2.76% | +4.34% | +10.20% | +18.74% | 9.41 B USD | ||
| 965 | IBRX ImmunityBio, Inc. - Common Stock | 8.64 USD | -1.37% | -3.14% | +18.36% | +214.18% | 9.05 B USD | ||
| 974 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 136.27 USD | -3.25% | +10.05% | +38.35% | +81.38% | 8.76 B USD | ||
| 977 | TGTX TG Therapeutics, Inc. - Common Stock | 56.68 USD | -2.38% | +2.98% | +33.40% | +57.49% | 8.68 B USD | ||
| 978 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 318.11 USD | -1.80% | -2.45% | +23.29% | +567.32% | 8.87 B USD | ||
| 984 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.50 USD | -0.04% | +113.17% | +147.26% | +103.16% | 8.80 B USD | ||
| 999 | PCVX Vaxcyte, Inc. - Common Stock | 57.13 USD | -5.83% | +1.76% | +21.73% | +35.06% | 8.25 B USD | ||
| 1017 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 63.26 USD | -5.99% | +0.05% | +27.33% | +59.55% | 7.91 B USD | ||
| 1018 | APGE Apogee Therapeutics, Inc. - Common Stock | 133.53 USD | -0.01% | +0.59% | +59.57% | +149.17% | 8.27 B USD | ||
| 1022 | SYRE Spyre Therapeutics, Inc. - Common Stock | 90.69 USD | -3.76% | +3.44% | +24.28% | +279.30% | 7.88 B USD | ||
| 1024 | IMVT Immunovant, Inc. - Common Stock | 38.97 USD | -2.79% | +2.28% | +24.03% | +102.86% | 8.00 B USD |
Noticias Biotechnology Stocks
BofA reitera su calificación de Beam Therapeutics tras fallo arbitral
¿Por qué cae hoy la acción de Beam Therapeutics?
¿Por qué las acciones de Prime Medicine se disparan hoy?
La acción de Incyte alcanza un máximo de 52 semanas en 118,77 dólares
Las acciones de Prime Medicine suben tras ganar arbitraje contra Beam
Resultados de Nurix Therapeutics: la atención se centra en el acuerdo con Roche
Las acciones de Edgewise Therapeutics alcanzan máximos históricos a 43,96 dólares
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |